Wondering if Johnson & Johnson is a bargain or overpriced right now? You are not alone. Plenty of investors are questioning ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Johnson & Johnson has delivered a standout performance in 2025, outperforming both the broader market and the healthcare ...

Johnson & Johnson (NYSE:JNJ – Free Report) had its target price lifted by Bank of America from $161.00 to $175.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has a ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Johnson & Johnson. Looking at options history for Johnson & Johnson (NYSE: JNJ) we detected 8 trades. If we consider the ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

In recent trading, shares of Johnson & Johnson (Symbol: JNJ) have crossed above the average analyst 12-month target price of $175.77, changing hands for $176.64/share. When a stock reaches the target ...

Jameson Private Wealth Management increased its JNJ position by 39,471 shares, with an estimated trade value of $6.76 million based on the quarter’s average price The trade represents a 0.86% change ...

Johnson & Johnson JNJ and MerckMRK are leading U.S. healthcare giants, making them natural peers for a head-to-head comparison. Both companies have a strong presence in oncology, ...